Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
about
The isoprostanes--25 years laterSystemic markers of oxidative status and colorectal adenomatous polyps.Urinary biomarkers of oxidative status.Cross-Classification of Human Urinary Lipidome by Sex, Age, and Body Mass Index.Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI.Systemic oxidative stress, as measured by urinary allantoin and F(2)-isoprostanes, is not increased in Down syndromeQuantification of fatty acid oxidation products using online high-performance liquid chromatography tandem mass spectrometry.A metabolic biosignature of early response to anti-tuberculosis treatment.Isoprostanes and asthma.Analysis of lipid peroxidation biomarkers in extremely low gestational age neonate urines by UPLC-MS/MS.Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals.Effects of 2 years of caloric restriction on oxidative status assessed by urinary F2-isoprostanes: The CALERIE 2 randomized clinical trial.Short-term effects of dietary advanced glycation end products in ratsA ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hour values in healthy volunteers in a controlled constant diet
P2860
Q33601352-CC6329F5-82F2-47FC-851B-CAFC1ECC9C15Q36094808-33A4F7BF-241B-478F-9D3E-180D1B2EC25DQ36178739-D683AB1D-2BE2-48AE-ADFC-4106BFFC5B36Q36223677-A43E4538-D2CC-41B5-895C-1D980BBCDFB2Q36279253-06E55C43-D8FB-4BCE-89C7-437DD15389EBQ36428399-CAF363DB-2E1C-4F61-A430-7A1660BC6CF6Q37169596-EC4631C7-6006-40BF-A322-5844C614B975Q37569320-FE94FF28-E0A4-4658-BF4A-C67A4711A8B4Q37877309-ADE7BC05-E9FE-4B20-B516-792FEB390258Q39194532-80D28036-3BAE-42CD-B976-AB7F1B4C145FQ44106187-59AD780D-2007-4523-B7EA-ADE821A4776FQ50051785-6B3DBD45-3B97-4589-8752-4A2E56AFA2B3Q57236993-CE7C2DC7-88BA-4850-A1F8-FEB0C1B4AF27Q57715709-967838C5-B6E7-4040-8529-7435D75A6FDF
P2860
Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quantification of the oxidativ ...... aphy-tandem mass spectrometry.
@ast
Quantification of the oxidativ ...... aphy-tandem mass spectrometry.
@en
type
label
Quantification of the oxidativ ...... aphy-tandem mass spectrometry.
@ast
Quantification of the oxidativ ...... aphy-tandem mass spectrometry.
@en
prefLabel
Quantification of the oxidativ ...... aphy-tandem mass spectrometry.
@ast
Quantification of the oxidativ ...... aphy-tandem mass spectrometry.
@en
P2093
P2860
P356
P1476
Quantification of the oxidativ ...... aphy-tandem mass spectrometry.
@en
P2093
David S Millington
Dora Il'yasova
Frances Wang
Haoyue Zhang
Judit Sztaray
Sarah P Young
P2860
P304
P356
10.1016/J.AB.2009.12.024
P407
P577
2009-12-22T00:00:00Z